Jim Cramer praised Johnson & Johnson, predicting a 10-point rally after a surprise quarter. The company develops healthcare products and medical technologies. While JNJ has potential, AI stocks may offer greater upside and less risk. Consider investing in undervalued AI stocks benefiting from Trump-era tariffs and onshoring trends.

Read more at Yahoo Finance: “J&J is Just Beginning Its Move”